Sort by
Medicine and Dentistry
Abdominal Wall
14%
Angiosarcoma
21%
Bariatric Surgery
42%
Body Mass Index
39%
Breast Cancer
14%
Cancer
23%
Cholecystectomy
15%
Connective Tissue Cancer
49%
Crohn's Disease
22%
Cytoreductive Surgery
22%
Disease Specific Survival
14%
Diseases
62%
Elderly Patient
27%
Gastric Bypass
68%
Gastric Bypass Surgery
68%
Gastroesophageal Reflux
14%
Hyperthermic Intraperitoneal Chemotherapy
23%
Intraductal Papillary Mucinous Tumor
23%
Intraperitoneal Chemotherapy
16%
Laparoscopic Sleeve Gastrectomy
21%
Liposarcoma
23%
Lymph Node
24%
Lymph Node Metastasis
35%
Malignant Neoplasm
21%
Metastatic Carcinoma
27%
microRNA
18%
Neoplasm
100%
Obesity Medicine
26%
Overall Survival
56%
Pancreas Adenocarcinoma
29%
Pancreas Cancer
22%
Pancreas Islet Cell Tumor
16%
Pancreaticoduodenectomy
18%
Peritoneum Metastasis
19%
Postoperative Complication
36%
Prognostic Factor
14%
Protein Kinase B
16%
Quality of Life
16%
Recurrent Disease
69%
Reoperation
17%
Retroperitoneal Sarcoma
76%
Roux-en-Y Gastric Bypass
15%
Sarcoma Cell
14%
Sleeve Gastrectomy
61%
Soft Tissue Sarcoma
85%
Surgeon
18%
Surgical Anastomosis
76%
Surgical Oncology
22%
Survival Rate
14%
Tissue Microarray
25%
Keyphrases
Angiosarcoma
17%
Bariatric
14%
Bariatric Surgery
45%
Body Mass Index
31%
Breast
22%
Chemotherapy
23%
Colorectal Cancer
16%
Cytoreductive Surgery
22%
Dedifferentiated
15%
Disease-specific Survival
17%
Elderly Patients
27%
FOLFIRINOX
16%
Gastric Bypass
16%
Human Soft Tissue
15%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
34%
Intraductal Papillary mucinous Neoplasm
21%
Israel
15%
Laparoscopic Sleeve Gastrectomy
27%
Local Recurrence
23%
Lymph Node Metastasis
31%
Metabolic Surgery
35%
Metastasis
14%
Multivariable
16%
Neoadjuvant
16%
One-anastomosis Gastric Bypass
54%
Overall Survival
42%
Pancreatic Cancer
14%
Pancreatic Ductal Adenocarcinoma
26%
Pancreaticoduodenectomy
18%
Peritoneal Metastasis
20%
Postoperative Complications
24%
Postoperative Mortality
16%
Prognosticator
17%
Resection
46%
Retroperitoneal Liposarcoma
17%
Retroperitoneal Sarcoma
86%
Retrospective Analysis
22%
Revisional
14%
Roux-en-Y Gastric Bypass
16%
Sarcoma
31%
Sarcoma Cells
24%
Sleeve Gastrectomy
64%
Soft Tissue Sarcoma
79%
Surgical Oncology
19%
Tertiary Care Hospital
21%
Tissue Microarray
23%
Total Weight Loss
16%
Tumor
51%
Weight Loss
14%
Well-differentiated
15%